Mark Baldry
Corporate Officer/Principal at X4 PHARMACEUTICALS, INC.
Net worth: 34 319 $ as of 2024-03-30
Profile
Mark Baldry is currently the Chief Commercial Officer at X4 Pharmaceuticals, Inc. He previously held positions at Biogen, Inc. as Vice President-Public Affairs, Amicus Therapeutics, Inc. as SVP-Global Marketing & Commercial Operations, Shire Plc as Head-Marketing & Market Access EMEA, Wave Life Sciences Ltd.
as Chief Commercial Officer, Wave Life Sciences USA, Inc. as Chief Commercial Officer, and Freeline Therapeutics Holdings Plc as Chief Commercial Officer.
Mr. Baldry received his undergraduate degree from York University and his MBA from Concordia University.
Known holdings in public companies
| Company | Date | Number of shares | Valuation | Valuation date |
|---|---|---|---|---|
X4 PHARMACEUTICALS, INC.
0.01% | 2024-02-12 | 24,690 ( 0.01% ) | 34 319 $ | 2024-03-30 |
Mark Baldry active positions
| Companies | Position | Start |
|---|---|---|
| X4 PHARMACEUTICALS, INC. | Corporate Officer/Principal | 2022-10-25 |
Former positions of Mark Baldry
| Companies | Position | End |
|---|---|---|
Wave Life Sciences USA, Inc.
 Wave Life Sciences USA, Inc. Electric UtilitiesUtilities Part of Wave Life Sciences Ltd., Wave Life Sciences USA, Inc. is a private company that provides nucleic acid therapeutics. The company is based in Cambridge, MA. The company was founded in 2012 by Gregory L. Verdine, Takeshi Wada. The CEO is Paul B. Bolno. | Corporate Officer/Principal | 2020-01-31 |
| AMICUS THERAPEUTICS, INC. | Sales & Marketing | 2019-06-30 |
| BIOGEN INC. | Public Communications Contact | 2015-04-30 |
| FREELINE THERAPEUTICS HOLDINGS PLC | Corporate Officer/Principal | - |
| WAVE LIFE SCIENCES LTD. | Corporate Officer/Principal | - |
Training of Mark Baldry
| York University | Undergraduate Degree |
| Concordia University | Masters Business Admin |
Experiences
Positions held
Connections
1st degree connections
1st degree companies
Male
Female
Members of the board
Executives
Linked companies
| Listed companies | 4 |
|---|---|
| BIOGEN INC. | Health Technology |
| AMICUS THERAPEUTICS, INC. | Health Technology |
| WAVE LIFE SCIENCES LTD. | Health Technology |
| X4 PHARMACEUTICALS, INC. | Health Technology |
| Private companies | 3 |
|---|---|
Shire Plc
 Shire Plc Pharmaceuticals: MajorHealth Technology Shire Plc is a biopharmaceutical company, which engages in the research, development, licensing, manufacturing, marketing, distribution, and sale of medicines. Its products include adderall, advate, adynovate, agrylin, antithrombin 3, aralast, bebulin, buccolam, feiba, firazyr, and foznol. The company was founded in 1986 and is headquartered in Dublin, Ireland. | Health Technology |
Wave Life Sciences USA, Inc.
Wave Life Sciences USA, Inc. Electric UtilitiesUtilities Part of Wave Life Sciences Ltd., Wave Life Sciences USA, Inc. is a private company that provides nucleic acid therapeutics. The company is based in Cambridge, MA. The company was founded in 2012 by Gregory L. Verdine, Takeshi Wada. The CEO is Paul B. Bolno. | Utilities |
Freeline Therapeutics Holdings Plc
 Freeline Therapeutics Holdings Plc BiotechnologyHealth Technology Freeline Therapeutics Holdings Plc engages in the business of developing and commercializing gene therapies. It also develops gene therapies for bleeding and other debilitating disorders. The company was founded by Markus Hörer and Amit Chunilal Nathwani in 2015 and is headquartered in Stevenage, the United Kingdom. | Health Technology |
- Stock Market
- Insiders
- Mark Baldry
